Directory

>

Jonathan Leith

Jonathan Leith

Vice President, Early Development Program Leads, Hematology, Oncology and Cell Therapy. | BRISTOL MYERS SQUIBB FARMACEUTICA

United States

View contact details (it's free)

Jonathan Leith

Summary

Jonathan Leith is a seasoned executive in the biotechnology and pharmaceutical industries, currently serving as Vice President, Early Development Program Lead at Bristol-Myers Squibb. With a robust educational background, including a PhD in Immunology/Virology from the University of Toronto, he has dedicated over two decades to advancing drug development and clinical research. Jonathan's expertise spans across various therapeutic areas including hematology, oncology, and infectious diseases. He has led cross-functional teams through critical development phases, showcasing his strong leadership capabilities. His role involves overseeing a diverse pipeline of assets, further solidifying his position as a key player in early drug development. Jonathan is passionate about leveraging innovative approaches to enhance patient outcomes in complex disease areas. His commitment to advancing medical science is evident in his strategic contributions to clinical trials and regulatory affairs.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Emerging Technologies

Leadership Development

Innovation

Organisational experience

Corporate Experience

Jonathan Leith

Work Experience

company logo

Vice President, Early Development Program Leads, Hematology, Oncology and Cell Therapy. at

Bristol Myers Squibb

April 2024 - Present

company logo

Vice President, Early Development Program Lead at

BRISTOL MYERS SQUIBB FARMACEUTICA

November 2019 - Present

company logo

Vice President Full Development Lead Hematology at

BRISTOL MYERS SQUIBB FARMACEUTICA

February 2016 - November 2019

💼

Vice President Full Development Lead, Immuno-Oncology and Oncology; IO Strategy. at

Bristol Myers Squibb Princeton New Jersey

November 2010 - November 2019

company logo

Head of Clinical Mechanisms, Translational Medicine at

BRISTOL MYERS SQUIBB FARMACEUTICA

March 2018 - November 2019

company logo

Vice President, Development Lead, Breast Cancer and Hematology, Oncology Development at

BRISTOL MYERS SQUIBB FARMACEUTICA

September 2017 - November 2019

company logo

Vice President, Full Development Lead Oncology at

BRISTOL MYERS SQUIBB FARMACEUTICA

February 2010 - December 2010

company logo

Therapeutic Lead Director Virology and Oncology at

Tibotec

January 2008 - January 2010

💼

Director Clinical at

Tibotec Johnson And Johnson

January 2006 - January 2008

💼

Clinical, Director at

Tibotec Canada A Division Of Janssen Ortho

January 2006 - February 2007

company logo

Global Medical Lead VIRAMUNE at

Boehringer Ingelheim (schweiz) Gmbh

February 2004 - August 2006

💼

Immunology at

Bi Etc

January 2001 - January 2003

Logos provided by Logo.dev

Jonathan Leith

Education

University of Toronto, Phd

January 1997 - January 2001

McMaster University, M.Sc

January 1995 - January 1997

McMaster University, Msc

January 1990 - January 1994

Frequently Asked Questions about Jonathan Leith

What is Jonathan Leith email address?

Jonathan Leith's primary email address is **************@bms.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Jonathan Leith work for?

Jonathan Leith is a Vice President, Early Development Program Leads, Hematology, Oncology and Cell Therapy. at BRISTOL MYERS SQUIBB FARMACEUTICA, a company specializing in Diagnostic substances.

Where Jonathan Leith graduated from?

Jonathan Leith holds a degree in Immunology / Virology from University of Toronto.

How can I directly contact Jonathan Leith?

To contact Jonathan Leith directly, you can use the email address **************@bms.com. Complete contact information is available upon registration with Muraena.

Who is Jonathan Leith?

Jonathan Leith is a seasoned executive in the biotechnology and pharmaceutical industries, currently serving as Vice President, Early Development Program Lead at Bristol-Myers Squibb. With a robust educational background, including a PhD in Immunology/Virology from the University of Toronto, he has dedicated over two decades to advancing drug development and clinical research. Jonathan's expertise spans across various therapeutic areas including hematology, oncology, and infectious diseases. He has led cross-functional teams through critical development phases, showcasing his strong leadership capabilities. His role involves overseeing a diverse pipeline of assets, further solidifying his position as a key player in early drug development. Jonathan is passionate about leveraging innovative approaches to enhance patient outcomes in complex disease areas. His commitment to advancing medical science is evident in his strategic contributions to clinical trials and regulatory affairs.

Jonathan`s contact details

mail

**************@bms.com

******@bristol.com.br

Colleagues

Michael Cucolo

Executive Director Business Development, Transactions

avatar
Sandra Leung

Executive Vice President, General Counsel

avatar
Stephane Strebelle

Executive Director Finance, US Commercialization FP&A

Mel Blumenthal

Executive Director, GCR

avatar
Danshi Li

VP, Global development Program Lead

Ed Scully

Senior Print and Premium Specialist

avatar
Carolyn Dzierba

Executive Director, Head of Immunology and Neuroscience Chemistry

Mary Struthers

Scientific Vice President

avatar
Maurice Bellfield

Executive Director | Head of Strategy & Operations | Chief of Staff

View Contact details (it's free)
Request Profile Removal